RGN-259 for neurotrophic keratopathy
NIHR HSRIC
Record ID 32016000685
English
Authors' recommendations:
Neurotrophic keratitis is a condition in which the cornea, the clear front part of the eye, becomes damaged. It is caused by nerve damage which leads to ulcers forming on the cornea. It can be very difficult to treat and some patients will need eye surgery.
RGN-259 is a new drug for the treatment of neurotrophic keratitis that is given as eye drops. Some studies have suggested the RGN-259 may be helpful for people who already have quite severe damage to their eye.
If RGN-259 is licensed for use in the UK, it could be a new treatment option for patients with this condition, which could reduce the need for surgery.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
http://www.hsric.nihr.ac.uk/topics/rgn-259-for-neurotrophic-keratopathy/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Humans
- Keratitis
- Trigeminal Nerve Diseases
- Cornea
- Ophthalmic Solutions
- Ophthalmologic Surgical Procedures
Contact
Organisation Name:
NIHR Horizon Scanning Centre
Contact Address:
The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
c.packer@bham.ac.uk
Contact Email:
c.packer@bham.ac.uk
Copyright:
NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.